Genentech (NYSE:DNA) formerly known as (NYSE:GNE)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Genentech (NYSE:DNA) formerly known as (NYSE:GNE)

An SI Board Since July 1999

Posts	SubjectMarks	Bans	Symbol
250	46	0	DNA

Emcee: esecurities(tm)	Type: Unmoderated

Introduction Market Data Compact

Genentech (DNA), The Biotechnology Juggernaut [tPA, Herceptin, Protropin...] Formerly Known As Genentech (GNE).

[June 18, 1999] "...Genentech, Inc. today announced Roche has formally exercised its option to cause Genentech to redeem all of its outstanding special common shares not owned by Roche.' on 'Jun 18, 1999'...The German pharmaceuticals giant will exercise its options to acquire the rest of the biotech company's shares it doesn't already hold and then re-issue shares in the company so that it may continue to trade as a distinct entity..."

Hoover's Profile of pending (NYSE:DNA) IPO hoovers.com

esecurities.com, DaytradersNewswire.com (tm), SiliconNewswire.com (tm), MicrocapNewswire.com (tm), WallStreetRadio.com (tm), DayTradersCafe.com (tm).

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
250	A Tribute to Genentech: siliconinvestor.com	DewDiligence_on_SI	1	3/28/2009
249	MARCH 12, 2009, 6:40 A.M. ET 4th UPDATE: Roche Seals $46.8B Genentech Deal By	kenhott	-	3/12/2009
248	Genentech, Roche Deal Hits Snag By MATTHEW KARNITSCHNIG and DANA CIMILLUCA, WSJ	kenhott	-	3/11/2009
247	Now seeing WSJ teasers crossing my newsfeed to the effect that Roche and DNA agr	tuck	-	3/11/2009
246	MARCH 9, 2009, 2:29 P.M. ET Genentech, Roche Near a Deal By MATTHEW KARNITSCHN	kenhott	-	3/9/2009
245	WSJ teaser just came across the wires to the effect that DNA is near a deal for	tuck	-	3/9/2009
244	March near-the-money puts prices come way in. New deadline is Fri Mar 20th, mid	kenhott	-	3/6/2009
243	Bingo! >>Roche Increases Offer Price for Genentech Shares to US$ 93.00 pe	tuck	-	3/6/2009
242	>>UPDATE 3-Genentech gives long-term forecast to rebuff Roche Mon Mar 2, 2	tuck	-	3/2/2009
241	>>Roche Holding EUR5.25B 4-Year Tranche Sets Record Last update: 2/25/2009	tuck	-	2/25/2009
240	>>Genentech Receives Final Notification Upholding Cabilly Patent in Reexam	tuck	-	2/24/2009
239	R&D day moved up to this coming Monday >>FOCUS: Roche May Soften Har	tuck	-	2/24/2009
238	FDA issues warning for Genentech drug Raptiva Silicon Valley / San Jose Business	nigel bates	-	2/20/2009
237	>>Roche $16B Multi-Tranche Launched; Largest US Bond Deal Ever Last update	tuck	-	2/18/2009
236	WSJ <i>It’s a long way from the $89 a share Roche initially offered to pa	tom pope	-	2/10/2009
235	market seems to be saying (a) - pfffft.	tom pope	-	2/10/2009
234	OK, since you persist. I'll even upfront say I voted for d). My version of	tuck	-	2/10/2009
233	Did you take the survey in #msg-25379009? If not, there's still time :-)	DewDiligence_on_SI	-	2/9/2009
232	Roche just filed to officially initiate the tender offer. Let the games begin.	tuck	-	2/9/2009
231	Roche’s in-house pipeline (such as it is): siliconinvestor.com [scan to chart]	DewDiligence_on_SI	-	2/5/2009
230	After the favorable Tarceva/Avastin results - <i> NEW YORK (AP) -- Docto	tom pope	-	2/4/2009
229	Roche-DNA Survey, Part Deux: siliconinvestor.com	DewDiligence_on_SI	-	2/2/2009
228	I looked thru the Dealbook article and I think they are making the same sort of	kenhott	-	2/2/2009
227	Here's an analysis of the tender offer by Dealbook, involving the the affili	tuck	-	2/2/2009
226	Roche restarts talks on Genentech jumbo loan Tue Jan 27, 2009 2:32pm GMT By Zai	kenhott	-	2/2/2009

Go to reply# or date (mm/dd/yy):